FullHope Biomedical Co., Ltd.

FullHope Biomedical Co., Ltd. is a biotechnology company specializing in the research, development, and commercialization of precision diagnostic solutions and regenerative medicine products. The company’s core expertise lies in developing platforms for immune function analysis and circulating tumor cell detection, delivering detailed insights into patients’ immune system status and providing critical information for disease management and follow-up treatment strategies. As part of its regenerative medicine portfolio, FullHope Biomedical operates a Good Tissue Practice (GTP) compliant laboratory, where it manufactures a variety of immune cell and stem cell-based products. The company’s offerings also include specialized testing services such as endotoxin and mycoplasma detection, supporting the safety and quality control needs of biopharmaceutical research. Founded in 2012 and headquartered in Taipei, FullHope Biomedical plays a significant role in advancing biotechnology and medical research within the healthcare sector, catering to the scientific, clinical, and commercial needs of medical institutions and research organizations across Taiwan.